CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
38.69
-1.21 (-3.03%)
Mar 9, 2026, 1:05 PM EDT - Market open
CONMED Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,375 | 1,307 | 1,245 | 1,045 | 1,011 | Upgrade
|
| Revenue Growth (YoY) | 5.18% | 5.00% | 19.06% | 3.45% | 17.18% | Upgrade
|
| Cost of Revenue | 634.15 | 573.98 | 568.5 | 469.73 | 442.6 | Upgrade
|
| Gross Profit | 740.58 | 733.03 | 676.25 | 575.75 | 568.04 | Upgrade
|
| Selling, General & Admin | 556.12 | 519.33 | 505.46 | 441.42 | 414.73 | Upgrade
|
| Research & Development | 55.88 | 54.43 | 52.6 | 47.15 | 43.57 | Upgrade
|
| Operating Expenses | 612 | 573.75 | 558.06 | 488.57 | 458.29 | Upgrade
|
| Operating Income | 128.57 | 159.28 | 118.18 | 87.17 | 109.74 | Upgrade
|
| Interest Expense | -31.09 | -37.3 | -39.78 | -28.91 | -35.49 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.42 | - | - | - | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | 97.07 | 121.98 | 78.41 | 58.27 | 74.21 | Upgrade
|
| Merger & Restructuring Charges | -12.9 | - | - | -14.6 | - | Upgrade
|
| Other Unusual Items | -13.05 | 41.05 | 2.42 | -114.53 | -1.1 | Upgrade
|
| Pretax Income | 71.12 | 163.03 | 80.83 | -70.86 | 73.11 | Upgrade
|
| Income Tax Expense | 24.06 | 30.61 | 16.37 | 9.72 | 10.56 | Upgrade
|
| Net Income | 47.06 | 132.42 | 64.46 | -80.58 | 62.54 | Upgrade
|
| Net Income to Common | 47.06 | 132.42 | 64.46 | -80.58 | 62.54 | Upgrade
|
| Net Income Growth | -64.47% | 105.44% | - | - | 557.16% | Upgrade
|
| Shares Outstanding (Basic) | 31 | 31 | 31 | 30 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 31 | 31 | 32 | 30 | 32 | Upgrade
|
| Shares Change (YoY) | -0.00% | -1.26% | 5.02% | -6.75% | 9.34% | Upgrade
|
| EPS (Basic) | 1.52 | 4.29 | 2.10 | -2.68 | 2.14 | Upgrade
|
| EPS (Diluted) | 1.51 | 4.25 | 2.04 | -2.68 | 1.94 | Upgrade
|
| EPS Growth | -64.47% | 108.33% | - | - | 506.25% | Upgrade
|
| Free Cash Flow | 150.88 | 153.88 | 106.32 | 11.58 | 96.9 | Upgrade
|
| Free Cash Flow Per Share | 4.84 | 4.94 | 3.37 | 0.39 | 3.01 | Upgrade
|
| Dividend Per Share | 0.600 | 0.800 | 0.800 | 0.800 | 0.800 | Upgrade
|
| Dividend Growth | -25.00% | - | - | - | - | Upgrade
|
| Gross Margin | 53.87% | 56.08% | 54.33% | 55.07% | 56.21% | Upgrade
|
| Operating Margin | 9.35% | 12.19% | 9.49% | 8.34% | 10.86% | Upgrade
|
| Profit Margin | 3.42% | 10.13% | 5.18% | -7.71% | 6.19% | Upgrade
|
| Free Cash Flow Margin | 10.98% | 11.77% | 8.54% | 1.11% | 9.59% | Upgrade
|
| EBITDA | 201.65 | 229.74 | 188.36 | 154.59 | 177.19 | Upgrade
|
| EBITDA Margin | 14.67% | 17.58% | 15.13% | 14.79% | 17.53% | Upgrade
|
| D&A For EBITDA | 73.08 | 70.46 | 70.17 | 67.42 | 67.44 | Upgrade
|
| EBIT | 128.57 | 159.28 | 118.18 | 87.17 | 109.74 | Upgrade
|
| EBIT Margin | 9.35% | 12.19% | 9.49% | 8.34% | 10.86% | Upgrade
|
| Effective Tax Rate | 33.83% | 18.77% | 20.25% | - | 14.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.